Vertex Pharmaceuticals Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2009 | 78.01x | $0.55 | $42.85 |
| Dec 2010 | 49.20x | $0.71 | $35.03 |
| Dec 2011 | 5.12x | $6.48 | $33.21 |
| Dec 2012 | 5.89x | $7.12 | $41.90 |
| Dec 2013 | 14.45x | $5.14 | $74.30 |
| Dec 2014 | 49.48x | $2.40 | $118.80 |
| Dec 2015 | 30.02x | $4.19 | $125.83 |
| Dec 2016 | 10.72x | $6.87 | $73.67 |
| Dec 2017 | 15.46x | $9.69 | $149.86 |
| Dec 2018 | 14.13x | $11.73 | $165.71 |
| Dec 2019 | 13.79x | $15.88 | $218.95 |
| Dec 2020 | 10.02x | $23.59 | $236.34 |
| Dec 2021 | 7.35x | $29.88 | $219.60 |
| Dec 2022 | 8.31x | $34.75 | $288.78 |
| Dec 2023 | 10.62x | $38.33 | $406.89 |
| Dec 2024 | 9.39x | $42.89 | $402.70 |
| Dec 2025 | 9.60x | $47.25 | $453.74 |